| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on EXELIXIS, INC. |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
EXELIXIS, INC.
The most promising biotech firm in the US? |
| Mean consensus |
BUY |
| Number of Analysts |
13 |
| Average target price |
30,83 $ |
| Last Close Price |
22,22 $ |
| Spread / Highest target |
66,5% |
| Spread / Average Target |
38,8% |
| Spread / Lowest Target |
12,5% |
Consensus revision (last 18 months)
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
